163 related articles for article (PubMed ID: 22490442)
1. The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice.
Xiang Y; Peng J; Tai N; Hu C; Zhou Z; Wong FS; Wen L
J Immunol; 2012 May; 188(10):4747-58. PubMed ID: 22490442
[TBL] [Abstract][Full Text] [Related]
2. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis.
Hamel KM; Cao Y; Ashaye S; Wang Y; Dunn R; Kehry MR; Glant TT; Finnegan A
J Immunol; 2011 Nov; 187(9):4900-6. PubMed ID: 21948985
[TBL] [Abstract][Full Text] [Related]
3. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
5. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
Kanagawa O; Militech A; Vaupel BA
J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
7. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.
Szczepanik M; Akahira-Azuma M; Bryniarski K; Tsuji RF; Kawikova I; Ptak W; Kiener C; Campos RA; Askenase PW
J Immunol; 2003 Dec; 171(11):6225-35. PubMed ID: 14634139
[TBL] [Abstract][Full Text] [Related]
8. B6.g7 mice reconstituted with BDC2·5 non-obese diabetic (BDC2·5NOD) stem cells do not develop autoimmune diabetes.
Rajasekaran N; Wang N; Hang Y; Macaubas C; Rinderknecht C; Beilhack GF; Shizuru JA; Mellins ED
Clin Exp Immunol; 2013 Oct; 174(1):27-37. PubMed ID: 23795893
[TBL] [Abstract][Full Text] [Related]
9. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
10. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
11. Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice.
Horikawa M; Weimer ET; DiLillo DJ; Venturi GM; Spolski R; Leonard WJ; Heise MT; Tedder TF
J Immunol; 2013 Feb; 190(3):1158-68. PubMed ID: 23275601
[TBL] [Abstract][Full Text] [Related]
12. Following immunization antigen becomes concentrated in a limited number of APCs including B cells.
Byersdorfer CA; Dipaolo RJ; Petzold SJ; Unanue ER
J Immunol; 2004 Dec; 173(11):6627-34. PubMed ID: 15557153
[TBL] [Abstract][Full Text] [Related]
13. B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes.
Egia-Mendikute L; Arpa B; Rosell-Mases E; Corral-Pujol M; Carrascal J; Carrillo J; Mora C; Chapman H; Panosa A; Vives-Pi M; Stratmann T; Serreze D; Verdaguer J
Front Immunol; 2019; 10():1732. PubMed ID: 31428087
[TBL] [Abstract][Full Text] [Related]
14. CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome.
Fribourg M; Cioni M; Ghiggeri G; Cantarelli C; Leventhal JS; Budge K; Bin S; Riella LV; Colucci M; Vivarelli M; Angeletti A; Perin L; Cravedi P
Front Immunol; 2021; 12():726428. PubMed ID: 34621271
[TBL] [Abstract][Full Text] [Related]
15. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope.
Jaume JC; Parry SL; Madec AM; Sønderstrup G; Baekkeskov S
J Immunol; 2002 Jul; 169(2):665-72. PubMed ID: 12097368
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.
Sentís A; Diekmann F; Llobell A; de Moner N; Espinosa G; Yagüe J; Campistol JM; Mirapeix E; Juan M
Immunobiology; 2017 Apr; 222(4):620-630. PubMed ID: 27986304
[TBL] [Abstract][Full Text] [Related]
20. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
